The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of intratumoral heterogeneity on prognostic biomarkers in localized prostate cancer.
 
Harry Brastianos
No Relationships to Disclose
 
Jure Murgic
No Relationships to Disclose
 
Adriana Salcedo
No Relationships to Disclose
 
Melvin Lee Kiang Chua
Stock and Other Ownership Interests - Merrimack (I); Pluristem Therapeutics (I); Varian Medical Systems
Honoraria - AstraZeneca; Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Ferring; Varian Medical Systems
Research Funding - Ferring; GenomeDx; Medlever (Inst); Medlever (Inst); Varian Medical Systems
Travel, Accommodations, Expenses - Apollo; Ferring; Varian Medical Systems
 
Alice Meng
No Relationships to Disclose
 
Michael Fraser
No Relationships to Disclose
 
Michael Donald Brundage
No Relationships to Disclose
 
Neil Eric Fleshner
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Spectracure (Inst)
 
Theodorus van der Kwast
No Relationships to Disclose
 
Robert G. Bristow
Research Funding - GenomeDx
 
Paul Christopher Boutros
Patents, Royalties, Other Intellectual Property - Holds patents on multiple biomarkers
 
Alejandro Berlin
No Relationships to Disclose